Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01773694 · ClinicalTrials.gov registry record · NA

Impact of Early Post-Operative Water Exposure on Complications of Cutaneous Surgeries

A NA study, sponsored by Milton S. Hershey Medical Center.

Completed
Registry status
NA
Development phase
507
Enrollment target

NCT01773694: Completed NA study, sponsored by Milton S. Hershey Medical Center.

NCT01773694 is a NA study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 507 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01773694, a NA study, has completed, sponsored by Milton S. Hershey Medical Center.

COMPLETED
Registry status
NA
Development phase
507 participants
Enrollment target

Study Summary

Patients are often counseled to keep a surgical wound dry for 2 to 3 days. The rationale is likely to decrease the risk of infection and bleeding. However, this has never been formally studied. Patient's routines are likely disrupted when they are asked to avoid wetting the area. The investigators will perform a controlled study to determine if avoidance of post-operative wetting is necessary.

Interventions

  • BEHAVIORAL Early Water Exposure

Trial Details

FieldValue
Enrollment Target 507 participants
Start Date 2013-03
Est. Completion 2020-10-16
Phase NA
Milton S. Hershey Medical Center

396 total trials

What the finished NCT01773694 record still lists

NCT01773694 is an interventional study that assigns participants to a tested intervention. The registered 507 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower).

The record links to 0 conditions, and to 1 intervention - of which Early Water Exposure is the first listed.

NCT01773694 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01773694 about?

NCT01773694 is a clinical study titled "Impact of Early Post-Operative Water Exposure on Complications of Cutaneous Surgeries". Patients are often counseled to keep a surgical wound dry for 2 to 3 days. The rationale is likely to decrease the risk of infection and bleeding. However, this has never been formally studied. Patient's routines are likely disrupted when they are asked to avoid wetting the area. The investigators w...

What is the current status of trial NCT01773694?

This trial is currently completed. It is a NA study. The enrollment target is 507 participants. The study started on 2013-03. Estimated completion is 2020-10-16.

What interventions are being tested in trial NCT01773694?

The interventions under investigation include: Early Water Exposure (BEHAVIORAL).

Who is sponsoring clinical trial NCT01773694?

This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01773694's enrollment target sits among peer trials

507 193rd of 2000 higher than 1,808 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06164717 · 507 participants · NA

    Behavioral and Neural Characteristics of Adaptive Speech Motor Control

  • NCT02115295 · 508 participants · Phase 2

    Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia

  • NCT04692675 · 508 participants · NA

    Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer

  • NCT07391657 · 508 participants · Phase 3

    A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01773694, the US trial registry maintained by the National Library of Medicine. NCT01773694 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.